Published Paper Details:

polycystic ovary syndrome is one of the most common endocrine disorders that affect approximately 6- 20% of women of childbearing age. It is characterized by hyperandrogenism and ovarian dysfunction along with metabolic disorders. Anovulation, hirsutism, obesity, insulin resistance and dyslipidemia may appear as clinical symptoms of polycystic ovary syndrome. There is increased risk of type 2 diabetes and cardiometabolic risk particularly in presence of obesity. Women with polycystic ovary syndrome are at high risk of obesity which further leads to metabolic, psychological and reproductive changes. Drugs like metformin, combined oral contraceptive pills, Spironolactone, play a key role in polycystic ovary syndrome. Polycystic ovary syndrome is not curable, but symptoms can be managed, hence lifestyle modification including proper diet, exercise and behavioral management remain the primary and most effective prevention strategy for polycystic ovary syndrome management.